Correlation Between LadRx and Orgenesis
Can any of the company-specific risk be diversified away by investing in both LadRx and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LadRx and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LadRx and Orgenesis, you can compare the effects of market volatilities on LadRx and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LadRx with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of LadRx and Orgenesis.
Diversification Opportunities for LadRx and Orgenesis
Poor diversification
The 3 months correlation between LadRx and Orgenesis is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding LadRx and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and LadRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LadRx are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of LadRx i.e., LadRx and Orgenesis go up and down completely randomly.
Pair Corralation between LadRx and Orgenesis
If you would invest 237.00 in LadRx on September 22, 2024 and sell it today you would earn a total of 0.00 from holding LadRx or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.16% |
Values | Daily Returns |
LadRx vs. Orgenesis
Performance |
Timeline |
LadRx |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
LadRx and Orgenesis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LadRx and Orgenesis
The main advantage of trading using opposite LadRx and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LadRx position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.LadRx vs. NovaBay Pharmaceuticals | LadRx vs. InMed Pharmaceuticals | LadRx vs. GeoVax Labs | LadRx vs. Phio Pharmaceuticals Corp |
Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |